40 mg capsules, delayed release formulation, bottle of 30
Indications and Usage:
Oracea is indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients.
Side Effects and Contraindications:
In clinical trials, the most common adverse events reported were gastrointestinal upsets, nasopharyngitis/pain and nasal congestion/sinusitis. Oracea should not be used to treat microbial infections, and should be used only as indicated. This drug is contraindicated in people who have shown hypersensitivity to any of the tetracyclines, and like other tetracycline drugs, may cause fetal harm when administered to a pregnant woman. Oracea should not be used during pregnancy, by nursing mothers or during tooth development (up to age of 8 years). Although photosensitivity was not observed in clinical trials, Oracea patients should minimize or avoid exposure to natural or artificial sunlight. All contraindications, warnings and precautions associated with tetracyclines must be considered before prescribing Oracea. The safety of Oracea treatment beyond 9 months has not been established.
Galderma Laboratories, L.P.